“It is not yet clear whether there may be a subgroup of people with Parkinson’s disease who may get benefit from the use of exenatide,” he added. He said that there will be more research to ...

In a plenary session at the annual American Academy of Neurology meeting, Paul Edison, MD, PhD, of Imperial College London in ...

Another consideration is that the effect on disease progression was pretty ... Two-year data from a phase 3 trial of exenatide in Parkinson’s is due later this year and could help answer that ...

Parkinson's doesn't just affect movement and the brain—it may also impact the heart, according to new research from the ...

Fox was one of the first stars to shine a light on Parkinson's disease, following his diagnosis in the early 1990s. Through his ups and downs, he's remained open and public about his health ...